Claudia Regina Morris MD
Associate Professor, Pediatrics, Emory Univ Sch of Med
Join to view full profile
1405 Clifton Rd NEAtlanta, GA 30322
Phone+1 404-785-7141
Fax+1 404-785-7989
Dr. Morris is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Children's Hospital-OaklandResidency, Pediatrics, 1993 - 1996
Eastern Virginia Medical SchoolClass of 1993- UCSF Benioff Children’s Hospital OaklandFellowship, Pediatric Emergency Medicine (Pediatrics)
Certifications & Licensure
CA State Medical License 1994 - 2028
GA State Medical License 2012 - 2027
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Emergency Medicine
Clinical Trials
Publications & Presentations
PubMed
- Secretory Phospholipase Ain Patients With Sickle Cell Disease Hospitalized for Vaso-Occlusive Pain Episodes.Rawan Korman, Maria Yasmine, Dunia Hatabah, Noor Alzraikat, Frank Harris
Pediatric Blood & Cancer. 2026-10-01 - Balanced Fluid or 0.9% Saline in Children Treated for Septic Shock.Fran Balamuth, Scott L Weiss, Elliot Long, Graham C Thompson, Amanda S Artis
The New England Journal of Medicine. 2026-09-03 - Arginine Therapy for Sickle Cell Disease Acute Pain Episodes: The STArT Randomized Clinical Trial.Claudia R Morris, Dunia Hatabah, Rawan Korman, Fahd A Ahmad, Gladstone Airewele
JAMA. 2026-08-19
Press Mentions
Emory and Children's Healthcare of Atlanta Now Part of Nationwide Pediatric Emergency Research Network (PECARN)September 17th, 2019
Sickle Cell Disease: No Longer the Road Less TravelledDecember 4th, 2018
Arginine Therapy May Hold New Promise for Sickle Cell PainSeptember 17th, 2013
Grant Support
- Patient-Oriented Research in Arginine Deficiency SyndromesEMORY UNIVERSITY2018–2028
- Patient-Oriented Research in Arginine Deficiency SyndromesEMORY UNIVERSITY2018–2028
- 1/2 Sickel Cell Disease Treatment with Arginine Therapy (STArT Trial)EMORY UNIVERSITY2020–2026
- Glutamine Therapy For Hemolysis-Associated Pulmonary HypertensionFood And Drug Administration2009–2011
- Nitric Oxide As A Marker For Degree Of Vaso-Occlusion In Sickle Cell DiseaseNational Center For Research Resources2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
